MGIC (MTG) Q1 2026 Earnings Call Transcript

MGIC Investment reported first-quarter net income of $165 million and ROE of 13%, with book value per share up 10% year over year to $23.63. New insurance written rose 41% to $14 billion, while favorable reserve development of $31 million and $62 million of investment income supported results. Management reiterated relatively flat 2026 insurance in force, $190 million to $200 million of full-year operating expenses, and continued aggressive capital returns, including a new $750 million buyback authorization and a $0.15 dividend.

Analysis

MTG is still behaving like a high-quality capital return compounder, but the more interesting point is that its earnings power is becoming increasingly insensitive to top-line growth and more dependent on credit benignity plus buyback capacity. That combination tends to compress volatility: if insurance-in-force stays roughly flat and reserves keep releasing, equity returns can remain attractive even without much organic balance-sheet expansion. The market may be underappreciating how much of the current shareholder yield is effectively financed by persistent excess capital and a reinsurance structure that materially lowers regulatory asset needs.

The bigger second-order issue is that refinance activity cuts both ways. A richer refi mix can support NIW in the near term, but it also weakens persistency and can mechanically pressure in-force premium yield over time; that means the current earnings cadence may prove strongest in a mid-rate plateau, not in a sharp rally. If rates fall meaningfully, MTG likely gets a volume pop, but the incremental value per policy declines as newer, cleaner loans reset into the book and older, higher-yielding policies runoff faster.

Credit still looks benign, but the company is telegraphing gradual normalization in delinquencies and roll rates, which matters because the stock is priced more for steady reserve releases than for flat loss emergence. The key risk is not an abrupt credit event today; it is a slow reversion in cure dynamics combined with higher claim severity from newer, larger-balance vintages. That would not break the thesis quickly, but it would reduce the pace of reserve benefits and make the current payout rate harder to sustain at the same multiple.

Contrarian takeaway: the market may be treating this as a generic cyclical financial, when it is closer to a self-funded capital return machine with optionality on policy-driven mortgage market expansion. The main mispricing is likely in duration — investors may be over-discounting how long elevated capital returns can persist if housing remains affordability-constrained and underwriting stays disciplined. The stock is attractive on downside protection, but upside likely comes from repeated authorization increases and not from a dramatic re-rating on growth.

Key Decisions for Investors

• Long MTG common for 3-6 months into the next capital-return update; thesis is >100% payout persistence plus low credit volatility, with downside cushioned by buybacks and book value growth.
• Sell MTG put spreads at strikes below book value for 2-4 months; monetize the gap between stable credit and the market's tendency to overprice mortgage-insurer tail risk.
• Pair trade: long MTG / short a rate-sensitive housing-finance beneficiary that needs falling rates for earnings reacceleration; MTG is better positioned if rates stay in the 6%-6.5% range and refi stays only moderate.
• If MTG rallies hard on a rate-cut/refi narrative, trim into strength rather than chase; the best risk/reward is in the current plateau, where buybacks and steady premium yield matter more than incremental volume.
• Watch for any sign of worsening cure rates or reserve-release slowdown over the next 1-2 quarters; that would be the first signal to reduce exposure, because the stock's valuation support is tied more to reserve support than to growth.